Launch of unified proposition strategy streamlines the Company’s offerings Management has identified 13 solutions and 11 services that offer significant […]
ATLANTA, Aug. 01, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on […]